
DCTH
Delcath Systems Inc
$
11.010
- Overview
- Forecast
- Valuation

Line
|

Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
11.610
Open
11.370
VWAP
10.92
Vol
642.32K
Mkt Cap
368.09M
Low
10.575
Amount
7.01M
EV/EBITDA(TTM)
--
Total Shares
27.79M
EV
371.99M
EV/OCF(TTM)
--
P/S(TTM)
10.06
Delcath Systems, Inc. is an interventional oncology company. The Company is focused on the treatment of primary and metastatic liver cancers. The Company’s proprietary products, HEPZATO Kit (melphalan hydrochloride for Injection/Hepatic Delivery Syst...Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q1
FY2025Q2
FY2025Q3
16.83M
+436.1%
--
--
19.24M
+147.69%
--
--
22.17M
+97.98%
--
--
Estimates Revision
The market is revisingUpwardthe revenue expectations for Delcath Systems, Inc. (DCTH) for FY2025, with the revenue forecasts being adjusted by 12.45%over the past three months. During the same period, the stock price has changed by-13.03%.
Revenue Estimates for FY2025
Revise Upward

+12.45%
In Past 3 Month
Stock Price
Go Down

-13.03%
In Past 3 Month
4 Analyst Rating

99.82% Upside
Wall Street analysts forecast DCTH stock price to riseover the next 12 months. According to Wall Street analysts, the average 1-year price target for DCTH is 22.00USD with a low forecast of21.00USD and a high forecast of24.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
4 Buy
0 Hold
0 Sell
Strong Buy

99.82% Upside
Current: 11.010

Low
21.00
Averages
22.00
High
24.00
HC Wainwright & Co.
Swayampakula Ramakanth
Strong Buy
Maintains
$22 → $24
2025-03-07
Reason
Craig-Hallum
Chase Knickerbocker
Strong Buy
Maintains
$18 → $21
2025-01-17
Reason
HC Wainwright & Co.
Swayampakula Ramakanth
Strong Buy
Reiterates
$22
2025-01-14
Reason
HC Wainwright & Co.
Swayampakula Ramakanth
Strong Buy
Reiterates
$22
2024-11-11
Reason
HC Wainwright & Co.
Swayampakula Ramakanth
Strong Buy
Reiterates
$22
2024-10-18
Reason
Canaccord Genuity
John Newman
Strong Buy
Maintains
$21
2024-10-18
Reason
Stephens & Co.
Sudan Loganathan
Buy
Reiterates
$25
2024-08-06
Reason
HC Wainwright & Co.
Swayampakula Ramakanth
Strong Buy
Reiterates
$22
2024-08-06
Reason
Craig-Hallum
Chase Knickerbocker
Strong Buy
Initiates
$18
2024-06-28
Reason
HC Wainwright & Co.
Swayampakula Ramakanth
Strong Buy
Maintains
$20 → $22
2024-05-15
Reason
Valuation Metrics
The current forward P/E ratio for Delcath Systems Inc(DCTH.O) is -227.81, compared to its 5-year average forward P/E of -13.01. For a more detailed relative valuation and DCF analysis to assess Delcath Systems Inc 's fair value, click here.
Forward PE

N/A
5Y Average PE
-13.01
Current PE
-227.81
Overvalued PE
28.92
Undervalued PE
-54.94
Forward EV/EBITDA

N/A
5Y Average EV/EBITDA
-7.93
Current EV/EBITDA
19.36
Overvalued EV/EBITDA
19.64
Undervalued EV/EBITDA
-35.49
Forward PS

Fair
5Y Average PS
16.85
Current PS
4.40
Overvalued PS
32.62
Undervalued PS
1.08
Financials
Annual
Quarterly
FY2024Q4
YoY :
+2701.48%
15.10M
Total Revenue
FY2024Q4
YoY :
-126.88%
3.04M
Operating Profit
FY2024Q4
YoY :
-69.49%
-3.40M
Net Income after Tax
FY2024Q4
YoY :
-77.08%
-0.11
EPS - Diluted
FY2024Q3
YoY :
-57.91%
-3.86M
Free Cash Flow
FY2024Q3
YoY :
+23.09%
85.36
Gross Profit Margin - %
FY2024Q3
YoY :
-91.78%
-115.71
FCF Margin - %
FY2024Q3
YoY :
-100.36%
16.64
Net Margin - %
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds areBuying! The buying amount has increased 276.68% over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
2
851.0K
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
DCTH News & Events
Events Timeline
2025-03-06 (ET)
2025-03-06
08:12:17
Delcath Systems reports Q4 EPS (11c), consensus 1c

2025-01-13 (ET)
2025-01-13
07:16:38
Delcath Systems sees FY24 revenue $37.2M, consensus $34.52M

2025-01-13
07:14:11
Delcath Systems sees Q4 revenue $15.1M, consensus $12.42M

2024-12-02 (ET)
2024-12-02
07:59:05
FDA finishes review of Delcath's IND application of HEPZATO combo trial

2024-11-08 (ET)
2024-11-08
07:07:02
Delcath Systems reports Q3 EPS 6c, consensus (20c)

2024-10-17 (ET)
2024-10-17
08:42:43
Delcath Systems sees Q3 revenue $11.2M, consensus $9.45M

2024-08-27 (ET)
2024-08-27
08:58:34
Delcath Systems announces outcomes from independent study on PHP

News
5.0
03-27NewsfilterBeta Bionics Announces Board Appointment of Gerard Michel
5.0
03-14BusinesswireDelcath Systems, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
4.5
03-13SeekingAlphaStock selloff slashes needed-market cap for new Russell 2000 additions: Stephens
9.5
03-06BusinesswireDelcath Systems Reports Fourth Quarter and Full Year 2024 Results
3.0
03-05SeekingAlphaHere's the major earnings before the open tomorrow
3.0
03-04NASDAQ.COMDelcath Systems Q4 24 Earnings Conference Call At 8:30 AM ET
9.0
02-14BusinesswireDelcath Systems Announces Update to National Comprehensive Cancer Network Clinical Practice Guidelines for the Treatment of Metastatic Uveal Melanoma
2.0
02-10NASDAQ.COMDelcath Delivers 100% Gain In Less Than 6 Months
7.0
01-31Yahoo FinanceBiotech walks a 'tightrope' amid unclear funding, regulations
1.0
01-28Yahoo FinanceDelcath Systems to Participate at the BTIG Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
5.0
01-26Yahoo Financeretail investors who own 58% along with institutions invested in Delcath Systems, Inc. (NASDAQ:DCTH) saw increase in their holdings value last week
4.0
01-14BenzingaHC Wainwright & Co. Reiterates Buy on Delcath Systems, Maintains $22 Price Target
9.5
01-13Investing.comDelcath stock soars on Q4 and 2024 revenue beat By Investing.com
5.0
01-03BusinesswireDelcath Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
8.5
2024-12-30NewsfilterDelcath Systems Announces Additional $16.3 Million in Funding From Series E and E1 Warrant Exercises
2.0
2024-12-26BenzingaWhy Zoomcar Shares Are Trading Higher By Around 142%; Here Are 20 Stocks Moving Premarket
5.0
2024-12-17NewsfilterClear Street Launches Healthcare & Biotechnology Equity Research
9.0
2024-12-02NewsfilterDelcath Systems Announces FDA Clearance of IND Application for Phase 2 Clinical Trial of HEPZATO™ in Liver-Dominant Metastatic Colorectal Cancer
4.0
2024-11-11BenzingaHC Wainwright & Co. Reiterates Buy on Delcath Systems, Maintains $22 Price Target
9.5
2024-11-09Yahoo FinanceDelcath Systems Inc (DCTH) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...
People Also Watch

COLL
Collegium Pharmaceutical Inc
28.140
USD
-3.03%

ELVN
Enliven Therapeutics Inc
18.690
USD
-6.69%

CSWC
Capital Southwest Corp
19.780
USD
-9.14%

LMB
Limbach Holdings Inc
69.300
USD
-5.30%

KFRC
Kforce Inc
46.750
USD
-1.04%

INOD
Innodata Inc
29.970
USD
-10.08%

VTOL
Bristow Group Inc
26.890
USD
-9.95%

PRO
Pros Holdings Inc
16.680
USD
-7.95%

FWRG
First Watch Restaurant Group Inc
16.330
USD
-4.95%

IHS
IHS Holding Ltd
4.710
USD
-8.72%
FAQ

What is Delcath Systems Inc (DCTH) stock price today?
The current price of DCTH is 11.01 USD — it hasdecreased-8.25 % in the last trading day.

What is Delcath Systems Inc (DCTH)'s business?

What is the price predicton of DCTH Stock?

What is Delcath Systems Inc (DCTH)'s revenue for the last quarter?

What is Delcath Systems Inc (DCTH)'s earnings per share (EPS) for the last quarter?

What changes have occurred in the market's expectations for Delcath Systems Inc (DCTH)'s fundamentals?

How many employees does Delcath Systems Inc (DCTH). have?
